Dr. Iván R. González (@dr_ivanoncologo) 's Twitter Profile
Dr. Iván R. González

@dr_ivanoncologo

Medical Oncologist at Centro Oncológico Integral, Hospital Ángeles Puebla. Cancer treatment must be personalized to the individual needs of the patient.

ID: 515209390

linkhttps://linktr.ee/drivanromaricogonzalezespinoza calendar_today05-03-2012 07:37:51

9,9K Tweet

4,4K Followers

4,4K Following

Dr. Iván R. González (@dr_ivanoncologo) 's Twitter Profile Photo
Dr. Iván R. González
@dr_ivanoncologo

a month ago

🔍 Key findings from the IMbrave150 study in hepatocellular carcinoma: 1️⃣ 77.8% of patients with partial response (PR) and 28.5% with stable disease (SD) after treatment with atezolizumab + bevacizumab had durable responses. 2️⃣ Median progression-free survival was 23.2 months

🔍 Key findings from the IMbrave150 study in hepatocellular carcinoma: 1️⃣ 77.8% of patients with partial response (PR) and 28.5% with stable disease (SD) after treatment with atezolizumab + bevacizumab had durable responses. 2️⃣ Median progression-free survival was 23.2 months